血液透析治疗老年肾衰竭患者的临床效果
|
摘要
目的探讨血液透析治疗在老年肾衰竭患者中的临床效果。方法选取2013年1月～2016年12月我院收治的100例老年肾衰竭患者作为研究对象,根据电脑随机分配原则分为观察组和对照组,每组各50例。观察组采用血液透析治疗,对照组采用常规治疗,比较两组的存活率、临床各指标水平、并发症总发生率及治疗总有效率。结果观察组患者的存活率为96.00%,高于对照组的70.00%,差异有统计学意义(P<0.05);观察组患者治疗后的尿素氮(BUN)、肌酐(Cr)水平低于对照组,血红蛋白(Hb)、血清总蛋白(TP)水平高于对照组,差异均有统计学意义(P<0.05);观察组患者的并发症总发生率低于对照组,差异有统计学意义(P<0.05);观察组患者的治疗总有效率高于对照组,差异有统计学意义(P<0.05)。结论血液透析治疗老年肾衰竭患者效果显著,能显著提高患者的存活率,同时改善各项临床指标,降低并发症的发生,值得推广应用。
Objective To explore the clinical effect of hemodialysis in elderly patients with renal failure. Methods A total of 100 elderly patients with renal failure admitted to our hospital from January 2013 to December 2016 were selected as the research objects, they were divided into observation group and control group, according to the principle of computer random allocation, with 50 cases in each group. The observation group was treated with hemodialysis, while the control group was treated with routine therapy. The survival rate, clinical indicators, the total incidence of complications and the total effective rate of treatment were compared between the two groups. Results The survival rate of the observation group was 96.00%, which was higher than 70.00% of the control group, the difference was significant(P<0.05). After treatment, the levels of BUN and Cr in the observation group were lower than those in the control group,and the levels of hemoglobin(Hb) and total serum protein(TP) were higher than those in the control group, the differences were significant(P<0.05). The total incidence of complications in the observation group was lower than that in the control group, the difference was significant(P<0.05). The total effective rate of the observation group was higher than that of the control group, the difference was significant(P<0.05). Conclusion Hemodialysis treatment of elderly patients with renal failure has a significant effect, can significantly improve the survival rate of patients, improve the clinical indicators, reduce the incidence of complications, it is worthy of promotion and application.
Objective To explore the clinical effect of hemodialysis in elderly patients with renal failure. Methods A total of 100 elderly patients with renal failure admitted to our hospital from January 2013 to December 2016 were selected as the research objects, they were divided into observation group and control group, according to the principle of computer random allocation, with 50 cases in each group. The observation group was treated with hemodialysis, while the control group was treated with routine therapy. The survival rate, clinical indicators, the total incidence of complications and the total effective rate of treatment were compared between the two groups. Results The survival rate of the observation group was 96.00%, which was higher than 70.00% of the control group, the difference was significant(P<0.05). After treatment, the levels of BUN and Cr in the observation group were lower than those in the control group,and the levels of hemoglobin(Hb) and total serum protein(TP) were higher than those in the control group, the differences were significant(P<0.05). The total incidence of complications in the observation group was lower than that in the control group, the difference was significant(P<0.05). The total effective rate of the observation group was higher than that of the control group, the difference was significant(P<0.05). Conclusion Hemodialysis treatment of elderly patients with renal failure has a significant effect, can significantly improve the survival rate of patients, improve the clinical indicators, reduce the incidence of complications, it is worthy of promotion and application.
引文
[1]孔亚玲,周刚,陈蕊.老年慢性肾衰竭患者持续性血液透析治疗的临床疗效分析[J].川北医学院学报,2016,31(5):681-683.
[2]钟裕元,李会珍,郑东升,等.血液透析治疗老年肾衰竭患者的临床价值分析[J].临床合理用药杂志,2013,6(36):96-97.
[3]孙宏伟.持续性血液透析治疗老年慢性肾衰竭患者的临床疗效及不良反应观察[J].中国民康医学,2015,27(24):19-20.
[4]胡锦清.血液透析治疗老年肾衰竭患者的临床疗效观察[J].现代诊断与治疗,2014,25(22):5166-5167.
[5]陈素玉.对老年慢性肾衰竭患者进行血液透析治疗的效果探讨[J].当代医药论丛,2017,15(5):95-96.
[6]陈幸.老年慢性肾衰竭患者血液透析治疗的临床研究[J].中国老年保健医学,2016,14(6):98-99.
[7]张小荣.床边间歇性血液透析治疗老年重症肾衰竭患者疗效观察[J].基层医学论坛,2017,21(22):3008-3009.
[8]张善斌,肖劲逐,张国庆,等.老年肾衰竭患者移植术后移植体存活时间及其影响因素分析[J].广东医学,2016,37(21):3227-3230.
[9]汪萍,余华.不同补液方式对老年肾衰竭患者的影响[J].中国老年学杂志,2013,33(22):5749-5750.
[10]吴静华,赵惠芬,刘华玲,等.预防性护理对老年肾衰竭透析患者预防感染及提高生活质量的作用[J].国际护理学杂志,2015,34(3):401-403.
[11]邵丽娜.左旋肉毒碱治疗老年肾衰竭血液透析继发心力衰竭的疗效[J].医学临床研究,2017,34(11):2250-2252.
[12]钟裕元,李会珍,郑东升,等.血液透析治疗老年肾衰竭患者的临床价值分析[J].临床合理用药杂志,2013,6(36):96-97.
[13]胡刚.透析治疗老年肾衰竭患者的临床效果[J].中外医疗,2016,35(23):47-48.
[14]陈辉乐,徐昌隆,金领微,等.老年肾衰竭患者血液透析感染的危险因素分析[J].中华医院感染学杂志,2014,24(4):911-913.
[15]郭金宝.透析治疗老年肾衰竭患者的临床效果[J].中国继续医学教育,2017,9(2):127-128.
[2]钟裕元,李会珍,郑东升,等.血液透析治疗老年肾衰竭患者的临床价值分析[J].临床合理用药杂志,2013,6(36):96-97.
[3]孙宏伟.持续性血液透析治疗老年慢性肾衰竭患者的临床疗效及不良反应观察[J].中国民康医学,2015,27(24):19-20.
[4]胡锦清.血液透析治疗老年肾衰竭患者的临床疗效观察[J].现代诊断与治疗,2014,25(22):5166-5167.
[5]陈素玉.对老年慢性肾衰竭患者进行血液透析治疗的效果探讨[J].当代医药论丛,2017,15(5):95-96.
[6]陈幸.老年慢性肾衰竭患者血液透析治疗的临床研究[J].中国老年保健医学,2016,14(6):98-99.
[7]张小荣.床边间歇性血液透析治疗老年重症肾衰竭患者疗效观察[J].基层医学论坛,2017,21(22):3008-3009.
[8]张善斌,肖劲逐,张国庆,等.老年肾衰竭患者移植术后移植体存活时间及其影响因素分析[J].广东医学,2016,37(21):3227-3230.
[9]汪萍,余华.不同补液方式对老年肾衰竭患者的影响[J].中国老年学杂志,2013,33(22):5749-5750.
[10]吴静华,赵惠芬,刘华玲,等.预防性护理对老年肾衰竭透析患者预防感染及提高生活质量的作用[J].国际护理学杂志,2015,34(3):401-403.
[11]邵丽娜.左旋肉毒碱治疗老年肾衰竭血液透析继发心力衰竭的疗效[J].医学临床研究,2017,34(11):2250-2252.
[12]钟裕元,李会珍,郑东升,等.血液透析治疗老年肾衰竭患者的临床价值分析[J].临床合理用药杂志,2013,6(36):96-97.
[13]胡刚.透析治疗老年肾衰竭患者的临床效果[J].中外医疗,2016,35(23):47-48.
[14]陈辉乐,徐昌隆,金领微,等.老年肾衰竭患者血液透析感染的危险因素分析[J].中华医院感染学杂志,2014,24(4):911-913.
[15]郭金宝.透析治疗老年肾衰竭患者的临床效果[J].中国继续医学教育,2017,9(2):127-128.